Floatz logo

Letrozole

Neoplasms

TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)Small moleculePhase 2Active
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
65/ 100

Competitive context

927 Active assets in the Neoplasms cohort.

Asset / SponsorPhaseRating
PANITUMUMAB
Astellas Pharma Inc
Phase 2BBB
GRANULOCYTE COLONY-STIMULATING FACTOR LENOGRASTIM
Sanofi
Phase 4BB
Bxcl501
Medical College of Wisconsin
Phase 4BB
Relatlimab
Bristol-Myers Squibb
Phase 2BB
Inno-206
The First Affiliated Hospital of Soochow University
Phase 2/3BB

View all 50 →

Same molecule, other indications

Letrozole is also rated in:

infertility disorderDormant
BBB
Indicative ·
79 / 100
View asset →
anovulationDormant
BBB
Indicative ·
78 / 100
View asset →
Diabetes MellitusDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →